Amneal Pharmaceuticals, Inc. (AMRX) vs Hims & Hers Health, Inc. (HIMS)

A side-by-side comparison of Amneal Pharmaceuticals, Inc. and Hims & Hers Health, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — AMRX vs HIMS

growth of $100 · dividends reinvested · last 7y
AMRX +488.2% (+28.8%/yr)HIMS +202.8% (+17.1%/yr)AMRX compounded faster over this window
0200400600Start $100202120232025$588$303
AMRX HIMS

AMRX vs HIMS: by the numbers

  • •HIMS is the larger company ($6.54B vs $6.50B market cap).
  • •AMRX is profitable (5.05% net margin) while HIMS runs a net loss (-5.51%).
  • •HIMS grew revenue faster over the past five years (67.47% vs 8.67% CAGR).

Metrics side by side

Valuation

MetricAMRXHIMS
P/E ratio41.78N/A
Forward P/E19.90N/A
P/S ratio2.092.54
P/B ratio196.9720.18
EV / EBITDA15.34N/A
FCF yield1.28%1.37%

Profitability

MetricAMRXHIMS
Gross margin39.32%73.84%
Operating margin12.93%4.50%
Net margin5.05%-5.51%
ROE476.51%-43.83%
ROIC13.45%-4.30%

Growth (annualized)

MetricAMRXHIMS
Revenue CAGR (5Y)8.67%67.47%
EPS CAGR (5Y)-17.72%N/A
FCF CAGR (5Y)-14.46%N/A
Total return CAGR (5Y)30.25%32.23%

Frequently asked

Which has grown faster, AMRX or HIMS?
Over the past five years, HIMS grew revenue faster — AMRX at a 8.67% CAGR versus HIMS at 67.47%.
Is AMRX or HIMS more profitable?
AMRX runs the higher net margin — AMRX at 5.05% versus HIMS at -5.51%.
How have AMRX and HIMS total returns compared?
Over the past 5 years, AMRX delivered 30.25% and HIMS delivered 32.23% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.